Brand name: Arzerra
Arzerra is a medicine containing the active ingredient(s) ofatumumab. On this page you will find out more about Arzerra, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: ofatumumab
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Arzerra 100 mg/5 mL concentrated injection, 3 x 5 mL vials
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
1. Previously Untreated CLL: ARZERRA is indicated, in combination with chlorambucil or bendamustine, for the treatment of patients with chronic lymphocytic leukaemia (CLL) who have not received prior therapy and are inappropriate for fludarabine-based therapy.,2. Refractory CLL: ARZERRA, as a single agent, is indicated for the treatment of patients chronic lymphocytic leukaemia (CLL) refractory to fludarabine and alemtuzumab.
Table of characteristics
| Active ingredient | |
|---|---|
| Visual appearance | A clear to hazy, colourless to pale yellow liquid, pratically free of visible particles. |
| Dosage Form | Injection, concentrated |
| Route of administration | Intravenous Infusion |
| Medicine schedule |
3 vials: Prescription Only Medicine, or Prescription Animal Remedy
|
There is one type of pack available.
Pack type 1
| Type | Vial |
|---|---|
| Storage temperature | Store at 2 to 8 degrees Celsius |
| Storage conditions | Protect from Light |
| Life time | 3 Years |
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
